Ulmus pumila Linné (Ulmi) Extract Attenuates Inflammatory Responses in Atopic Dermatitis by Modulating Lipid Peroxidation and Oxidative Stress
Antioxidants · 29.05.2026 · 15 (6) · 683
DOI: 10.3390/antiox15060683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 29.05.2026. Verfasst von Min Jung Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Background
Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by oxidative stress and impaired skin barrier function. These pathological features contribute to persistent inflammation and symptom exacerbation, highlighting the need for therapies that can both reduce oxidative stress and modulate inflammatory pathways.
Methods
Ulmus pumila Linné (Ulmi) was prepared via hot water extraction and tested for cytotoxicity, antioxidant activity, and anti-inflammatory effects in HaCaT keratinocytes stimulated with tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ). In vivo efficacy was assessed using a 2,4-dinitrochlorobenzene (DNCB)-induced AD model in SKH-1 hairless mice. Bioactive compounds were identified using liquid chromatography–quadrupole time-of-flight tandem mass spectrometry (LC-QTOF-MS/MS), and molecular docking analysis was performed to evaluate the binding affinity of these compounds to aldehyde dehydrogenase 2 (ALDH2).
Results
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays confirmed that Ulmi was safe at concentrations up to 400 μg/mL. In TNF-α/IFN-γ-stimulated HaCaT cells, Ulmi significantly upregulated ALDH2 expression in a dose-dependent manner and reduced reactive oxygen species (ROS) production. The extract also suppressed pro-inflammatory mediators such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), while inhibiting the activation of nuclear factor kappa B (NF-κB) and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathways. In the AD mouse model, Ulmi treatment improved clinical skin scores, reduced epidermal thickness, and decreased inflammatory markers compared to untreated controls. LC-QTOF-MS/MS analysis identified eight bioactive compounds, with procyanidin B2, catechin, and epicatechin as major constituents. Molecular docking revealed that procyanidin B2 had the strongest binding affinity to ALDH2 (−9.5 kcal/mol).
Conclusions
These findings demonstrate that Ulmi effectively ameliorates AD-like symptoms through ALDH2-mediated antioxidant mechanisms and anti-inflammatory effects. The results suggest that Ulmi may serve as a promising natural therapeutic agent for the management of atopic dermatitis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Veterinary Medicine, Gyeongsang National University, Jinju 52828, Republic of Korea.
- Preclinical Research Center, Daegu Gyeongbuk Medical Innovation Foundation (K-MEDI Hub), Daegu 41061, Republic of Korea.
- Center for Bio-Health Research, Division of Gyeongnam Bio-Environmental Research, Korea Institute of Toxicology (KIT), 17 Jeigok-gil, Jinju 52834, Republic of Korea.
- College of Korean Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.
- Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea.
ORCID-Profile: Mi Jin Jang, Gon Sup Kim, Young Woo Kim, Ju-Hye Yang, Kwang Il Park
Förderung
- National Research Foundation of Korea
- Korea Basic Science Institute
- Korea Health Industry Development Institute
- Korea Institute for Advancement of Technology
Zitieren
APA
Kim, M. J., Jang, M. J., You, Y. Z., Yang, Y. J., Heo, J. W., Kim, H. H., Kim, H. H., Jeong, S. H., Kim, G. S., Kim, Y. W., Yang, J. H., Jeon, R., An, S. H., & Park, K. I. (2026). Ulmus pumila Linné (Ulmi) Extract Attenuates Inflammatory Responses in Atopic Dermatitis by Modulating Lipid Peroxidation and Oxidative Stress. Antioxidants, 15(6), 683. https://doi.org/10.3390/antiox15060683
Vancouver
Kim MJ, Jang MJ, You YZ, Yang YJ, Heo JW, Kim HH, et al. Ulmus pumila Linné (Ulmi) Extract Attenuates Inflammatory Responses in Atopic Dermatitis by Modulating Lipid Peroxidation and Oxidative Stress. Antioxidants. 2026;15(6):683. doi:10.3390/antiox15060683
BibTeX
@article{Kim2026,
author = {Kim, Min Jung and Jang, Mi Jin and You, Young Zoo and Yang, Ye Jin and Heo, Ji Woong and Kim, Hee Ho and Kim, Hun Hwan and Jeong, Se Hyo and Kim, Gon Sup and Kim, Young Woo and Yang, Ju-Hye and Jeon, Ryounghoon and An, Sang-Hyun and Park, Kwang Il},
title = {Ulmus pumila Linné (Ulmi) Extract Attenuates Inflammatory Responses in Atopic Dermatitis by Modulating Lipid Peroxidation and Oxidative Stress},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {6},
pages = {683},
doi = {10.3390/antiox15060683}
}
EUVIMED